Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3

Overview of attention for article published in Arthritis Research & Therapy, December 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 3 news outlets
policy: 3 policy sources

twitter: 1 X user
f1000: 1 research highlight platform

Citations

dimensions_citation: 164 Dimensions

Readers on

mendeley: 145 Mendeley

Summary News Policy documents X Research highlights Dimensions citations

So far, Altmetric has seen 4 policy documents that reference this research output.

upadacitinib

Cited by Canadian Agency for Drugs and Technologies in Health on 25 Aug 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Ixekizumab for treating axial spondyloarthritis : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 21 Jul 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Secukinumab for treating non-radiographic axial spondyloarthritis : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 21 Jul 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Konsultationsfassung: Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen: Langfassung der Leitlinie "Konsultationsfassung: Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen"

Cited by The Association of the Scientific Medical Societies in Germany on 26 Mar 2019

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.